Medical Excellence Capital
Overview
Medical Excellence Capital is a life sciences venture capital firm that provides company creation, seed, and early-stage capital to innovators in precision medicine, cell therapy, gene therapy, and AI-driven drug discovery.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TwoStep Therapeutics | Sep 2026 | Series A | - |
| Truvian | Jul 2024 | VC Round | Co-investor |
| Immunitas Therapeutics | Aug 2021 | Series B | - |
| Avilar Therapeutics | Feb 2023 | Seed | Co-investor |
| GC Therapeutics | Sep 2024 | Series A | - |
For institutional investors. Book with your work email.
Key People
Brian Halak
Managing Partner
Eric Heil
Managing Partner
Joni Mancini
Managing Partner
Kim Kamdar
Managing Partner
Muhamad Furqon
Commercial Investment Partner Senior Partner, Audit And Risk Committee(semi-retired)
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Medical Excellence Capital based?
Medical Excellence Capital is headquartered in Nissequogue, New York, United States.
When was Medical Excellence Capital founded?
Medical Excellence Capital was founded in 2020.
How many portfolio companies does Medical Excellence Capital have?
Medical Excellence Capital has 11 portfolio companies in Caplight's dataset.
What are some companies in Medical Excellence Capital's portfolio?
Portfolio companies visible on Caplight include TwoStep Therapeutics, Truvian, Immunitas Therapeutics, Avilar Therapeutics, GC Therapeutics.
What was Medical Excellence Capital's most recent investment shown here?
Medical Excellence Capital's most recent investment in this portfolio sample was in TwoStep Therapeutics in 2026.
What sectors does Medical Excellence Capital focus on?
Medical Excellence Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software.
What company stages does Medical Excellence Capital focus on?
Medical Excellence Capital typically invests at the MultiStage stage.
What is Medical Excellence Capital's AUM?
Medical Excellence Capital's assets under management are estimated between $100.0M and $250.0M.